chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt vaccinated with DTP mother phoned MD since child cont. for 24 hrs w/fever of 103.7 even w/Tylenol q 4hrs. MD advised Ped DT only in future.
Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Hypotension-Severe, Additional Details: sweating profusely, EMS called and came to pharmacy, checked on pt and all clear for him to leave, parents had no problem and said they didnt need anything before they leave
This spontaneous report was received from a receptionist at the physician's office, via a sales representative, concerning a female friend of unknown age with sickness. On an unknown date, the patient was vaccinated with a dose of GARDASIL, (dosage, route, lot number and expiration date were not provided). Co-suspect therapy and concomitant medications were not provided. On an unknown date, it was reported that the patient got really sick after she received a dose of GARDASIL. The patient was sick before, and the GARDASIL made it worse. It was unknown if the patient received any treatment for the event, or if the patient sought medical attention. At the time of the report, the patient's outcome was unknown. The event was considered to be possibly related to suspect therapy, GARDASIL (made it worse). Additional information is not expected.
As requested I will attempt to document what transpired after the flu vaccine on Wednesday, 30 September 2009. Wednesday, 30 September: Flu vaccine at 7:30 a.m. Thursday evening while undressing: noticed raised red blotches around the site of the injection on left arm. Friday morning: red blotches appearing on back of hands. Friday evening: fish for dinner. Saturday morning: raised red blotches on chest and upper thighs. Skin shriveled up like "Benjamin Button" Sought medical advice ... informed that I had hives. Possibly a reaction to flu vaccine. However, after speaking with a representative of a facility, I was informed that Thimerasol was in the vaccine, which is also in fish [Friday's dinner]. Not being a medical person, I could have inadvertently overdosed on Thimerasol??????? Have been taking Benadryl [liquid every 4 hours]. Hives starting to disappear [Tuesday, October 6].  Patient reports that hives were gone by Wednesday October 7, 2009.
I had a fever of 101  for 3 days, sore throat, cough, running nose, congestion, and sneezing. One morning I had diarrhea and one night I had stomach cramps. To stop the diarrhea I took a modem. I test positive at home for COVID-19. I then called my doctor and he prescribed me Paxlovid. I tested negative on 10/04/2022 then tested positive again. I had a headache, sore throat, and coughing. I still have congestion, drainage and really bad sinus pressure.
Grandmother states child woke up the day after vaccination (i.e. 11/25/09) with high temperature and vomiting. Grandmother took child to doctor.
SHE CALLED AND LET ANOTHER PHARMACIST KNOW THAT SHE HAD 100 DEGREE TEMP AND A PINK GRAPEFRUIT SIZE RED MARK ON HER ARM. SHE ALSO DID NOT FEEL GOOD FOR 2 DAYS.
Rash on lower back/ Chin/ Ankle after 1st dose; Hives after 1st dose; Hot and itchy rash after 1st dose; This spontaneous case was reported by a health care professional and describes the occurrence of RASH (Rash on lower back/ Chin/ Ankle after 1st dose), URTICARIA (Hives after 1st dose) and PRURITUS (Hot and itchy rash after 1st dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced RASH (Rash on lower back/ Chin/ Ankle after 1st dose), URTICARIA (Hives after 1st dose) and PRURITUS (Hot and itchy rash after 1st dose). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) at an unspecified dose and frequency and HYDROCORTISONE (topical) at an unspecified dose and frequency. At the time of the report, RASH (Rash on lower back/ Chin/ Ankle after 1st dose), URTICARIA (Hives after 1st dose) and PRURITUS (Hot and itchy rash after 1st dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Soreness at injection site; Stiff neck; Shoulder soreness; Tingling sensation; This spontaneous case was reported by an other and describes the occurrence of VACCINATION SITE PAIN (Soreness at injection site), MUSCULOSKELETAL STIFFNESS (Stiff neck), ARTHRALGIA (Shoulder soreness) and PARAESTHESIA (Tingling sensation) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness at injection site), MUSCULOSKELETAL STIFFNESS (Stiff neck), ARTHRALGIA (Shoulder soreness) and PARAESTHESIA (Tingling sensation). At the time of the report, VACCINATION SITE PAIN (Soreness at injection site), MUSCULOSKELETAL STIFFNESS (Stiff neck), ARTHRALGIA (Shoulder soreness) and PARAESTHESIA (Tingling sensation) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication  provided was ibuprofen OTC . No concomitant medications were provided by reporter.
Migraine headache started at 8PM  on 04/22/2021. Intensity increased over next 26 hours. Took 2 Tylenol at 10PM on 04/23/2021.  Headache resolved by 6AM on 4/24/2021. Body aches started at 10PM on 4/22/2021 and continued through 6 AM on 04/24/2021. Blurred vision started at 1PM on 4/23/2021 and resolved by 6AM on 04/24/2021. Mild nausea started at 8PM on 4/22/2021 and resolved by 6AM on 4/24/2021.
Non-febrile seizure lasting for 10 seconds with URI symptoms and nonbloody loose stool.
dizzy and lightheaded couple minutes after  second dosage, corrected on own with no interventions
Itchiness in the injection site; Rash in the injection site; Redness in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness in the injection site), VACCINATION SITE RASH (Rash in the injection site) and VACCINATION SITE ERYTHEMA (Redness in the injection site) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness in the injection site), VACCINATION SITE RASH (Rash in the injection site) and VACCINATION SITE ERYTHEMA (Redness in the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchiness in the injection site), VACCINATION SITE RASH (Rash in the injection site) and VACCINATION SITE ERYTHEMA (Redness in the injection site) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided  by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: NNI, reporter states he did not report anything and denied to FU
pt recv vax; devel hives on lower extremities & torso, photosensitivity & dilated pupils;may3 exp n,v,"different stools" & numbness in hands & feet;f/u may have had GBS-type synd;
Severe vomiting + diarrhea 48 hours after vaccines given. Went on to develop URI sx's - v/d were <24 hours.
Patient is a 4 Y female here with mother for evaluation of a rash.  Mom states that she first noticed a few spots on her back on 11/1/09.  They spots start out light pink and then develop a little blister on them.  The spots are itchy at times, but overall, do not bother her.  She has otherwise been acting completely well.  She has not had a fever, congestion, cough, sore throat, headache or earache.  She has not had any nausea, vomiting or diarrhea.  She has been eating and drinking as usual.  No urinary symptoms. She has slowly developed more lesions, primarily on her back, neck and a few on her face.  No new lotions, soaps or detergents.  No one else at home with a rash.  She has been attending preschool per usual.  The last new spots were noticed three days ago. No specific ill exposures known.  She did have Varicella Vaccine 9/06.  Her second one is due next year.
Losing judgement; had few minor accidents; Is scared, and does not want to die on the street; High sugar levels; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (High sugar levels), CONFUSIONAL STATE (Losing judgement), ACCIDENT (had few minor accidents) and ANXIETY (Is scared, and does not want to die on the street) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced BLOOD GLUCOSE INCREASED (High sugar levels). On an unknown date, the patient experienced CONFUSIONAL STATE (Losing judgement), ACCIDENT (had few minor accidents) and ANXIETY (Is scared, and does not want to die on the street). At the time of the report, BLOOD GLUCOSE INCREASED (High sugar levels), CONFUSIONAL STATE (Losing judgement), ACCIDENT (had few minor accidents) and ANXIETY (Is scared, and does not want to die on the street) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medications  were provided.
2 days after vaccination the lymph nodes started to swell bilaterally, and then the right side nodes had returned to normal after a couple of days.  The main swelling of lymph node continues to be on the left side of the body on the upper neck, behind the jawline behind the ear.
local reaction at injection site, lump immediately after withdrawl needle with bruising - 5-10 min after patient complained of dizziness, sweating, and seeing spots - lasted 20-30 minutes with Nausea, paleness gave 20mg Depo-medrol IM at 10:45
Discomfort, tingling, numbness in a patch of skin w/ the right upper lateral thigh 2 days after ADACEL. (Lateral/femoral nerve distribution)
15 minutes after receiving the 1st dose of Pfizer covid vaccine, patient became restless, started vomiting, and complained of difficulty breathing with acute respiratory distress. Patient's friend answered no when asked if this happened to her before stating that this is something new. RN activated anaphylaxis protocol at the mobile site, local FD on site called dispatch, RN drew and administered 0.5 mg epinephrine IM to right vastus lateralis. After 5 minutes, patient reports breathing improved, feeling much better, no more vomiting, able to sit still and talk clearly, vital signs within normal limits, breath sounds normal. EMS arrived and turned over care to them. Patient refused to go with ambulance, signed AMA, friend reassured that he is going to take her to a medical center
Information has been received from a RN concerning a 19 year old black female pt with no past medical history and no allergies who on 03/24/03 and on 05/30/03 was vaccinated with varicella virus vaccine live (Lot # 643083/0572M). There was no concomitant medication. On 07/21/03 the pt had a negative titer.  The pt sought unspecified medical attention. There were no adverse symptoms noted.  Additional information has been requested.
Got first shot Moderna and second shot Pfizer; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Got first shot Moderna and second shot Pfizer) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient started TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Got first shot Moderna and second shot Pfizer). On 11-Mar-2021, INTERCHANGE OF VACCINE PRODUCTS (Got first shot Moderna and second shot Pfizer) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant and treatment drugs were provided.
ZERO APPETITE; NASAL CONGESTION; SLEEPING ALL DAY; EXTREME FATIGUE, TIREDNESS; PAIN ON THE INJECTION SITE; This spontaneous report received from a patient concerned a 69 year old male. The patient's height, and weight were not reported. The patient's past medical history included: covid, and two liver transplants, and concurrent conditions included: diabetes. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808986 and expiry: UNKNOWN) dose was not reported, administered on 01-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-SEP-2021, the patient experienced pain on the injection site. On 03-SEP-2021, the patient experienced zero appetite. On 03-SEP-2021, the patient experienced nasal congestion. On 03-SEP-2021, the patient experienced sleeping all day. On 03-SEP-2021, the patient experienced extreme fatigue, tiredness. On SEP-2021, treatment medications included: paracetamol.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from extreme fatigue, tiredness, nasal congestion, sleeping all day, and pain on the injection site, and had not recovered from zero appetite. This report was non-serious.
cyst in shoulder; Arm was a little sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was a little sore) and DERMAL CYST (cyst in shoulder) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026LZ0A and 010MZOA) for COVID-19 vaccination.     Concurrent medical conditions included BRCA1 gene mutation since 07-Apr-2014 and Allergy to antibiotic (to amoxicillin). Concomitant products included METHYLPREDNISOLONE ACETATE (MEDROL [METHYLPREDNISOLONE ACETATE]) for Shoulder pain.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm was a little sore) and DERMAL CYST (cyst in shoulder). At the time of the report, PAIN IN EXTREMITY (Arm was a little sore) and DERMAL CYST (cyst in shoulder) outcome was unknown.            No concomitant medications were reported.  Patient reported she finished 4mg Medrol dose pack few days before second dose of Moderna COVID-19 vaccine which she was taking for shoulder pain due to a cyst that ruptured and she does not think that the cyst occurred due to the Moderna COVID-19 vaccine as it was a few weeks after the shot.   This case was linked to MOD-2021-015853 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Patient information was updated, allergy to amoxicillin updated On 01-Jun-2021: patient sent MRI report which is unrelated to the case; Sender's Comments: Although the specific date was not provided.  However, based on the current available information which includes a temporal association between the use of mRNA-1273 and the start date of the reported events, a causal relationship with the event cannot be excluded.
thyroid storm, was given beta blocker (propranolol) and corticosteroid (dexamethasone) and hospitalized for 10 days
2 days following 2nd vaccine woke up with chest pain and was diagnosed with acute pericarditis. He was admitted for 2 days and monitored with imaging and labs. Ultimately heart showed good function and he was discharged home with ibuprofen for 10 days and cardiology follow up
This case was reported by a physician and described the occurrence of not responding to therapy in a subject of unspecified age and gender who was vaccinated with ENGERIX B (GlaxoSmithKline). On unspecified dates starting in October 2000, the subject received 1st, 2nd and 3rd dose of ENGERIX B (details unknown) per schedule. Approximately ten years after receiving 1st, 2nd, and 3rd doses of ENGERIX B, on an unspecified date in August 2010, the physician assessed an antibody titer and no antibodies were measured. The subject experienced not responding to therapy. At that time, on an unspecified date in August 2010, the subject received a 4th dose of ENGERIX B (details unknown). A second titer was drawn about six weeks later and still showed no antibodies and the subject experienced not responding to therapy for a second time. At the time of this report, the physician was not able to provide additional details due to pressure for time.
Large red bump at injection sight. Warm to the touch. Chills, body aches ,upset stomach & fatigue all day 10/09/2021 & 10/10/2021
Recv'd Hep A vax #2 on 2/23-started itching on 2/24 & developed rash on 2/25.Tx w/ Benadryl.Rash was less red by 2/26.
This case was reported by a nurse via sales rep and described the occurrence of swelling arm in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced swelling arm, erythema of extremities, influenza-like symptoms, fever, chills and pain. On an unknown date, the outcome of the swelling arm and erythema of extremities were recovered/resolved and the outcome of the influenza-like symptoms, fever, chills and pain were unknown. It was unknown if the reporter considered the swelling arm, erythema of extremities, influenza-like symptoms, fever, chills and pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient's arm swelled, was red and lasted for about 48 hours. The patient experienced flu like symptoms which were fever, chills and was achy. The reporter did not agree for follow up.
Miscarriage at 4 1/2 weeks.  Began bleeding 6 hours after receiving shot.
Patient received an improperly stored dose of PNEUMOVAX 23; Information has been received from a medical assistant regarding a patient of unknown age and gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 14-NOV-2019, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, for prophylaxis (lot number R009408 with expiration date in 07-MAR-2020 or lot number R005345 with expiration date in 01-MAR-2020) (route of administration, strength and anatomical location were not reported).  The pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was stored at the lowest temperature below36°F (34.5°F) for the time frame of 35 hours and 37 minutes. There was another temperature excursion below 36°F (34.4°F) for 83 hours and 11 minutes. The call was because of a data logger.
12.5 cm ax 11.5 cm area of erythema on (R) thigh at site of injections, slightly warm, started KEFLEX to cover for cellulitis, complete resolution by 5/20/13.
Chills, fever, body/aches, chills began around 4 am the morning after vaccination. Unable to walk/stand without becoming dizzy. Symptoms began to get better that same evening and terminated the following morning.
I got my first Covid vaccine (Pfizer) on March 24th, and 11 days later (on April 4th), I began having hives, which I'd never had in my life. They proceeded to get so bad that I needed to go to urgent care (twice), and get on steroids, antihistamines, etc. I did not initially think it had anything to do with the vaccine, but I was too scared to get my second shot. It took 2 months to clear up, going away completely in early/mid June. By then I was taking 2x Allegra, 2x Zyrtec, 2x famotidine (20mg each), and 10mg montelukast every day. I also added a vitamin D3 supplement (5000 IU) in May that immediately helped lessen my hives (at the time).  I then received my second dose of Pfizer on June 30th (after reassuring myself it was not the vaccine), and 13 days later, the hives returned. This time they lasted 4 months, and got progressively worse the entire time, resulting in more trips to urgent care and more rounds of steroids. Everything culminated in October, when they got the worst they'd been since April (despite all the drugs I was still on). I was tested for "everything," got on my 4th round of steroids, and doubled my famotidine to 80mg per day. They did not come back after that, although I am still taking some of my drugs, so I am not certain if they are truly gone, or just suppressed (but I think they are gone, finally).
ashen color dec BP, blue lips, vomiting,dilatation eyes, limpness w/in 20-30min of getting vax;
first "shingles vaccine" in 2020, never finished series.; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received 1st dose on an unknown date in 2020).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional Information: GSK Receipt Date: 23-MAY-2022 Reporter's Comments: The reporter stated that a patient received the first shingles vaccine in 2020 but never finished the series. The reporter stated she could not hear specialist. Specialist attempted to collect information several times, but reporter stated she could not understand or hear what specialist was saying. The reporter stated she would hung up and call back, but no further information was provided. The reporter did not consent to follow-up. Additional Supportive Information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.
For unknown reason (not documented in chart) patient received the first Moderna COVID-19 Vaccine dose on 07/21/21, the  second dose of Moderna COVID-19 Vaccine on 08/18/21 and the third/booster dose on 12/15/2021 which is earlier than the required 5 months and outside of the 4-day grace period. There were no adverse events associated with administration of the vaccine. Per CDC guidance, doses inadvertently administered earlier than the grace period should not be repeated.
Employee was given flu shot. Arm where injection given became very red/raised area. She did not complain of pain. SOB, etc. Slight rash did appear.
Day 8 developed itchy, red, quarter sized red mark at vaccine site.  Itching was deeper, not on surface.  Day 9 redness is larger in size, more itchy, there is a knot and it's sore.  Also has woken up sweaty past 3 days but denies fever.